entertainment -WSS

entertainment

author：leisure time 2025-10-02 21:07:37 - browse：1183

Scientist walks up a strand of DNA -- First Opinion coverage from STAT — Adobe

Eli Lilly said Tuesday that it will pay $200 million to gene-editing firm Beam Therapeutics for Beam’s stake in Verve Therapeutics, another gene-editing company focused on treatments for heart disease.

The deal, which also includes future milestone payments, is evidence that despite the pressure on biotechnology stocks there is still interest in very early cutting-edge technologies among big pharmaceutical players. It also provides Beam, which announced on Oct. 19 that it would cut 100 jobs, or 20% of its workforce, to save cash, a large infusion of money.

“This is like a true win-win-win deal, which is rare in this business, but it’s really, really exciting to see,” said John Evans, Beam’s CEO, in an interview with STAT.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Gene therapy has helped boys walk. Can scientists keep it that way?

WSS

Why we need to separate burnout from moral injury in health care

Ask STAT: What do you want to know about ChatGPT in medicine?

The woman behind the Dana Farber

What would happen to your eyes if you looked at the solar eclipse?

Chemotherapy shortages won’t get better under Biden’s latest plan

Paxlovid study fails to answer questions over benefit for broader groups

leisure time

entertainment

focus

BioMarin wins approval for gene therapy to treat hemophilia A

Spinal cord stimulation reduces pain in amputees, study finds

ChatGPT in medicine: STAT answers readers' burning questions

Obesity experts on risks of Wegovy, Ozempic weight loss drugs

The high cost of giving birth even with insurance

Cloning humans is technically possible. It's curious no one has tried

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Cloning humans is technically possible. It's curious no one has tried

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Cloning humans is technically possible. It's curious no one has tried

knowledge

Do masks work? RCTs can't tell us

Why are elite athletes different? Take a look at their microbes

Disclosing genetic information: not as worrisome as once feared

New guidelines on severe brain injury complicate already difficult decisions

AbbVie buys Immunogen, maker of targeted cancer drugs, for $10B

Why we need to separate burnout from moral injury in health care

hotspot

explore

focus

explore